Gilead Sciences (GILD) Net Income (2009 - 2026)

Gilead Sciences (GILD) has reported Net Income for 18 consecutive years, with $2.0 billion the latest figure, recorded in Q1 2026.

• Net Income for Q1 2026 came in at $2.0 billion, up 53.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.6 billion (up 60.3% YoY), and the FY2025 annual result was $8.5 billion, up 1676.62% from the prior year.
• Net Income was $2.0 billion for Q1 2026 at Gilead Sciences, down from $2.5 billion in the prior quarter.
• Over five years, Net Income peaked at $3.1 billion in Q3 2025 and troughed at -$4.2 billion in Q1 2024.
• Average Net Income over 5 years is $1.3 billion, with a median of $1.6 billion recorded in 2024.
• Year-over-year, Net Income soared 8100.0% in 2023 and plunged 523.88% in 2024.
• Over 5 years, Net Income stood at $1.6 billion in 2022, then retreated by 13.29% to $1.4 billion in 2023, then increased by 25.85% to $1.8 billion in 2024, then soared by 41.86% to $2.5 billion in 2025, then retreated by 20.06% to $2.0 billion in 2026.
• Per Business Quant data, the three most recent Net Income figures were $2.0 billion in Q1 2026, $2.5 billion in Q4 2025, and $3.1 billion in Q3 2025.